GPP
KBIO

Great Point Partners’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Great Point Partners’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-113,837
Closed -$2.08M – 50
2014
Q2 		$2.08M Buy
113,837
+46,725
+70% +$800K 0.92% 31
2014
Q1 		$1.46M Buy
+67,112
New +$1.94M 0.76% 32

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIM
SSI Investment Management Los Angeles, California $1.72B AUM 7.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Great Point Partners's KBIO Position: Q3 2014 in Review

Great Point Partners sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q3 2014, closing a stake of 113,837 shares — an estimated $2.08M sold.

Great Point Partners first reported a position in KBIO in Q1 2014 and held it in 2 quarters. The position peaked at $2.08M in Q2 2014. 35 funds tracked by Wall St. Rank hold KBIO as of Q3 2014.

  • Great Point Partners reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q3 2014 after selling out during the quarter.
  • Great Point Partners sold 113,837 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q3 2014, an estimated $2.08M.
  • Great Point Partners first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q1 2014 and held it in 2 quarters.
  • Great Point Partners's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $2.08M in Q2 2014.
  • 35 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q3 2014.

Based on Great Point Partners's 13F filing for Q3 2014, filed 14 Nov 2014.